標(biāo)題: Titlebook: Gastrointestinal Cancers: An Interdisciplinary Approach; Nima Rezaei Book 2023 The Editor(s) (if applicable) and The Author(s), under excl [打印本頁(yè)] 作者: Philanthropist 時(shí)間: 2025-3-21 19:48
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach影響因子(影響力)
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach被引頻次
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach被引頻次學(xué)科排名
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach年度引用
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach年度引用學(xué)科排名
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach讀者反饋
書(shū)目名稱(chēng)Gastrointestinal Cancers: An Interdisciplinary Approach讀者反饋學(xué)科排名
作者: TIGER 時(shí)間: 2025-3-21 21:31 作者: 銼屑 時(shí)間: 2025-3-22 03:39 作者: BIPED 時(shí)間: 2025-3-22 08:33
Gastrointestinal Cancers: An Interdisciplinary Approach978-3-031-48371-4Series ISSN 2731-4561 Series E-ISSN 2731-457X 作者: Yourself 時(shí)間: 2025-3-22 12:25 作者: RUPT 時(shí)間: 2025-3-22 16:15 作者: RUPT 時(shí)間: 2025-3-22 20:31
Atlas of Anatomy of the Peripheral Nervespic in the Medline and Web of Science databases. In the last 5?years, over 5500 papers on EMT in physiological, tumor, and non-tumor lesions have been issued annually. The first guideline for EMT research was edited in 2020 by the EMT International Association (TEMTIA). Despite rapidly growing inter作者: 尾巴 時(shí)間: 2025-3-22 22:06
Atlas of Anatomy of the peripheral nerveses. Despite recent advancements in diagnosis and treatment, gastrointestinal (GI) malignancies continue to rank among the most aggressive tumors and have a dismal prognosis. Metabolomics is the right method to explain the metabolic processes that belong to living systems and, being the dysregulated 作者: Heart-Attack 時(shí)間: 2025-3-23 04:53
Péter L?w,Kinga Molnár,Gy?rgy Kriskae, even if a steady decline in the incidence rate has been observed in the last few decades. Studies on the genetic landscape of GC have been published, and a molecular classification has been proposed, focusing on the possibility of using a specific target therapy for each group of patients. During作者: expansive 時(shí)間: 2025-3-23 06:57
Cloaca-Like Anomaly in the Maledering that, it is one of the reasons for late detection. Gastric cancer which is strongly related to the . infection is more common in East Asian countries and developing countries with low sanity levels. The prolonged infection with . increases the risk of developing gastric ulcers, thereby activa作者: 迅速成長(zhǎng) 時(shí)間: 2025-3-23 10:02 作者: Torrid 時(shí)間: 2025-3-23 17:55
https://doi.org/10.1007/978-3-7091-6580-5olorectal cancers remain the most common and lethal cancers globally. Emerging data suggest that in addition to the proliferating cancer cells, the tumor microenvironment plays an important role in deciding the fate of these cancers. Compelling evidence further suggests that among the components of 作者: 說(shuō)明 時(shí)間: 2025-3-23 21:29 作者: 完整 時(shí)間: 2025-3-24 00:56 作者: 反叛者 時(shí)間: 2025-3-24 03:20
Atlas of Astronomical Discoveriesth with an increasing incidence in younger patients. The association of this tumor with external modifiable factors such as life habits and diet is well known. In recent years, growing attention has been focused on the intestinal microbiota, the complex ecosystem made up of bacteria, viruses, and fu作者: Middle-Ear 時(shí)間: 2025-3-24 07:23
https://doi.org/10.1007/978-1-4757-9310-9g the cancers with the highest mortality rate. In the past, surgery, chemotherapy, radiotherapy, and their combination were the only solutions for cancer treatment; however, the emergence of immunotherapy has recently opened a new horizon in cancer treatment, especially hematological malignancies. A作者: 壓倒 時(shí)間: 2025-3-24 13:59
Low-density Lipoproteins in Atherogenesis,ethods, but the treatment efficacy is often hindered by inefficient tumour penetration and drug delivery. Hence, the development of drug nanocarrier is becoming more important in order to maximise the drug delivery to the target cells and the cancer-killing capacity. In recent years, the use of nano作者: saphenous-vein 時(shí)間: 2025-3-24 15:01
Niels Engberding,Nanette K. Wengerth advanced disease stage with requirements for multimodal treatment. Younger patients appear to have higher rates of treatment-related toxicities, giving rise to unique challenges for these patients. The impact of treatment-related morbidity on quality of life can be overlooked. Survivorship issues作者: 描述 時(shí)間: 2025-3-24 22:06 作者: 性上癮 時(shí)間: 2025-3-25 00:12
Basic Liver Pathology Terminologies,tered over many years. At the moment, prevention or early identification at a stage where treatment is still possible is exceptionally challenging because patients seldom show symptoms, and tumors exhibit no sensitive and specific indicators to help with detection. Most patients have advanced or met作者: Obliterate 時(shí)間: 2025-3-25 06:54 作者: ovation 時(shí)間: 2025-3-25 10:47
Niels Engberding,Nanette K. Wenger are increasingly relevant owing to the potential for long-term survival following treatment. Striking a balance between treating early-onset colorectal cancer while preserving bowel, bladder, sexual function, and fertility is challenging yet imperative.作者: 男學(xué)院 時(shí)間: 2025-3-25 12:39 作者: 數(shù)量 時(shí)間: 2025-3-25 15:59 作者: Malcontent 時(shí)間: 2025-3-25 20:03
The Tumor Microenvironment in Pancreatic Cancer and Challenges to Immunotherapy,tributes to the aggressive disease phenotype and treatment resistance. In this chapter, the different components of the TME in PDAC will be described and discussed to further elucidate some of the major challenges of the TME in relation to immunotherapy.作者: heterogeneous 時(shí)間: 2025-3-26 03:02 作者: Emasculate 時(shí)間: 2025-3-26 07:08 作者: 保全 時(shí)間: 2025-3-26 10:25 作者: CRUMB 時(shí)間: 2025-3-26 12:41 作者: 粘 時(shí)間: 2025-3-26 20:32
Atlas of Astronomical Discoveriesas a new therapeutic target and finally as a biomarker of response to conventional therapy. In the following paragraphs, we will elucidate the role of intestinal microbiota and immune system in CRC carcinogenesis as well as their interplay. Moreover, we will address the potential role of gut microbiota in CRC screening, diagnosis, and therapy.作者: Oscillate 時(shí)間: 2025-3-26 23:56
The Interplay Between Immunity and Gut Microbiota in Colon Cancer,as a new therapeutic target and finally as a biomarker of response to conventional therapy. In the following paragraphs, we will elucidate the role of intestinal microbiota and immune system in CRC carcinogenesis as well as their interplay. Moreover, we will address the potential role of gut microbiota in CRC screening, diagnosis, and therapy.作者: Phonophobia 時(shí)間: 2025-3-27 02:53
Gastrointestinal Cancers: An Interdisciplinary Approach作者: municipality 時(shí)間: 2025-3-27 08:54
Atlas of Anatomic Pathology with Imagingselective para-clinic and laboratory data used in the diagnostic approach, early diagnosis is challenging. Interdisciplinary studies over immune-related cells and their interactions with gene expression and mutation in the tumor microenvironment have recently added new insights into the diagnosis an作者: Common-Migraine 時(shí)間: 2025-3-27 13:23
Rachel Wetstone MPH,Martin Zaiac MDaffects the TME of gastrointestinal cancers. We discussed the multiple layers of the TME within the holobiont vision and examined how microbial dysbiosis could influence the mutual relationship between the host immunology and GM in several districts of the gastrointestinal tract, affecting oncogenes作者: 嬉耍 時(shí)間: 2025-3-27 14:28
Atlas of Anatomy of the Peripheral Nervesagus to the anal canal, and hepatic and pancreatic malignancies. Drawing on experimental studies, in vivo observations, and microscopic examinations of gastrointestinal cancers, the authors intend to highlight the most important features of EMT, which might guide oncologists in identifying the best 作者: 天氣 時(shí)間: 2025-3-27 20:39 作者: Yag-Capsulotomy 時(shí)間: 2025-3-27 23:19 作者: 柳樹(shù)；枯黃 時(shí)間: 2025-3-28 02:13 作者: 使害羞 時(shí)間: 2025-3-28 08:31
https://doi.org/10.1007/978-3-7091-6580-5evelopment of new and novel antitumor therapies. In this book chapter, we will discuss the important findings from studies investigating the roles of different neuromodulators in the growth and progression of gastric and colorectal cancers. We will summarize the roles of these important neurotransmi作者: cunning 時(shí)間: 2025-3-28 12:46
Dorsal Augmentation Using Autogenous Tissue,ltrates are a sign of poor outcome. Investigators comparing hematoxylin-eosin tumor-infiltrating lymphocyte evaluation and immunohistochemical lymphocytic subset studies came to stackable conclusions. To enter immune cells’ assessment in routine clinical practice, previous studies focused on possibl作者: 描述 時(shí)間: 2025-3-28 14:34 作者: 一條卷發(fā) 時(shí)間: 2025-3-28 20:30
https://doi.org/10.1007/978-1-4757-9310-9s rapidly evolving in the last decades. In this method, the patient’s T cells are manipulated to express desired CARs to recognize the tumor-associated antigens (TAAs). Some of the principal TAAs in GI cancers are epithelial cell adhesion molecule (EpCAM), mucin 1 (MUC1), human epidermal growth fact作者: Chagrin 時(shí)間: 2025-3-29 00:13 作者: Synovial-Fluid 時(shí)間: 2025-3-29 04:39
https://doi.org/10.1007/978-3-7091-3332-3 losing 15% of their baseline weight by 3?years. The primary causes of weight loss are often attributed to early satiety, dumping, reflux, and dysphagia; however, the underlying pathophysiology is incompletely characterized. Mechanistic studies looking at other operations which induce profound and s作者: 笨拙的我 時(shí)間: 2025-3-29 08:22
Basic Liver Pathology Terminologies,ic cancer immunosuppressive TME and underscore an extensive spectrum of immunotherapies, including oncolytic virus therapy, adoptive cell transfer therapy (i.e., T-cell receptor [TCR]-engineered T cells therapy, chimeric antigen receptor [CAR] T-cell therapy, CAR natural killer [NK] cell therapy, an作者: 公理 時(shí)間: 2025-3-29 11:53 作者: HUSH 時(shí)間: 2025-3-29 17:58
Book 2023ology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for researchers, oncologists, and gastroenterologists who wish to extend their knowledge on gastrointestinal cancers.?.作者: 傀儡 時(shí)間: 2025-3-29 23:20
Interdisciplinary Approach in Gastrointestinal Cancers,selective para-clinic and laboratory data used in the diagnostic approach, early diagnosis is challenging. Interdisciplinary studies over immune-related cells and their interactions with gene expression and mutation in the tumor microenvironment have recently added new insights into the diagnosis an作者: refraction 時(shí)間: 2025-3-30 02:07 作者: 諷刺 時(shí)間: 2025-3-30 06:23 作者: 發(fā)展 時(shí)間: 2025-3-30 10:39 作者: 行業(yè) 時(shí)間: 2025-3-30 13:45 作者: 勤勞 時(shí)間: 2025-3-30 19:44
Gastric Cancer and ,arly and interstitially, causing an immune inflammatory response that promotes gastric carcinogenesis. Recently, an increasing incidence of gastric cancer was observed in younger individuals in some countries, highlighting the need for more preventive strategies in younger populations. . also develo作者: 調(diào)色板 時(shí)間: 2025-3-30 22:54 作者: lacrimal-gland 時(shí)間: 2025-3-31 02:44 作者: 疾馳 時(shí)間: 2025-3-31 06:14 作者: yohimbine 時(shí)間: 2025-3-31 12:26 作者: MEN 時(shí)間: 2025-3-31 14:45 作者: delta-waves 時(shí)間: 2025-3-31 19:08
Unintentional Weight Loss and Malnutrition After Esophageal Cancer and Treatment, losing 15% of their baseline weight by 3?years. The primary causes of weight loss are often attributed to early satiety, dumping, reflux, and dysphagia; however, the underlying pathophysiology is incompletely characterized. Mechanistic studies looking at other operations which induce profound and s作者: 技術(shù) 時(shí)間: 2025-4-1 01:27
Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment,ic cancer immunosuppressive TME and underscore an extensive spectrum of immunotherapies, including oncolytic virus therapy, adoptive cell transfer therapy (i.e., T-cell receptor [TCR]-engineered T cells therapy, chimeric antigen receptor [CAR] T-cell therapy, CAR natural killer [NK] cell therapy, an作者: 沉著 時(shí)間: 2025-4-1 02:03
